C. Stehman-Breen

651 total citations
12 papers, 428 citations indexed

About

C. Stehman-Breen is a scholar working on Nephrology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, C. Stehman-Breen has authored 12 papers receiving a total of 428 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Nephrology, 3 papers in Public Health, Environmental and Occupational Health and 2 papers in Oncology. Recurrent topics in C. Stehman-Breen's work include Dialysis and Renal Disease Management (3 papers), Erythropoietin and Anemia Treatment (2 papers) and Bone health and treatments (2 papers). C. Stehman-Breen is often cited by papers focused on Dialysis and Renal Disease Management (3 papers), Erythropoietin and Anemia Treatment (2 papers) and Bone health and treatments (2 papers). C. Stehman-Breen collaborates with scholars based in United States, Netherlands and Sweden. C. Stehman-Breen's co-authors include David R. Gretch, Scott S. Emerson, R. A. Willson, Richard J. Johnson, Charles E. Alpers, Jodi M. Smith, Daniel L. Gillen, Craig S. Wong, Jason Brandt and Ruth A. McDonald and has published in prestigious journals such as Annals of the Rheumatic Diseases, The Journals of Gerontology Series A and American Journal of Kidney Diseases.

In The Last Decade

C. Stehman-Breen

12 papers receiving 415 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Stehman-Breen United States 8 220 162 105 103 49 12 428
Jay Bucci United States 11 284 1.3× 181 1.1× 259 2.5× 51 0.5× 27 0.6× 13 540
B. Erbay Türkiye 11 27 0.1× 124 0.8× 69 0.7× 124 1.2× 42 0.9× 20 401
G. Algarra Spain 9 68 0.3× 107 0.7× 102 1.0× 118 1.1× 23 0.5× 11 298
M Turan Türkiye 10 97 0.4× 96 0.6× 64 0.6× 41 0.4× 71 1.4× 42 367
Natanong Thamcharoen United States 8 75 0.3× 40 0.2× 66 0.6× 127 1.2× 39 0.8× 9 284
Paungpaga Lertdumrongluk Thailand 11 32 0.1× 37 0.2× 85 0.8× 235 2.3× 33 0.7× 16 390
Sofía Pedroso Portugal 15 84 0.4× 83 0.5× 331 3.2× 159 1.5× 122 2.5× 75 614
Mical S. Campbell United States 17 678 3.1× 529 3.3× 142 1.4× 31 0.3× 34 0.7× 27 896
A. Monegal Spain 13 140 0.6× 141 0.9× 15 0.1× 35 0.3× 40 0.8× 21 558
S Natov United States 14 391 1.8× 318 2.0× 172 1.6× 55 0.5× 19 0.4× 24 594

Countries citing papers authored by C. Stehman-Breen

Since Specialization
Citations

This map shows the geographic impact of C. Stehman-Breen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Stehman-Breen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Stehman-Breen more than expected).

Fields of papers citing papers by C. Stehman-Breen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Stehman-Breen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Stehman-Breen. The network helps show where C. Stehman-Breen may publish in the future.

Co-authorship network of co-authors of C. Stehman-Breen

This figure shows the co-authorship network connecting the top 25 collaborators of C. Stehman-Breen. A scholar is included among the top collaborators of C. Stehman-Breen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Stehman-Breen. C. Stehman-Breen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Maloney, Jennifer, A. Kivitz, Thomas J. Schnitzer, et al.. (2017). Fasinumab in the treatment of hip and knee osteoarthritic pain: efficacy and safety in a 36-week randomized, double-blind placebo-controlled clinical trial. Osteoarthritis and Cartilage. 25. S56–S57. 3 indexed citations
2.
GOLDEN, WILLIAM E., Daria B. Crittenden, Magdalena Uhart, et al.. (2015). AB0908 Findings From Denosumab (Prolia®) Postmarketing Safety Surveillance for Serious Infections. Annals of the Rheumatic Diseases. 74. 1204–1204. 2 indexed citations
3.
Geller, Michelle, Rachel B. Wagman, Pei‐Ran Ho, et al.. (2014). SAT0479 Early Findings from Prolia® Post-Marketing Safety Surveillance for Atypical Femoral Fracture, Osteonecrosis of the Jaw, Severe Symptomatic Hypocalcemia, and Anaphylaxis. Annals of the Rheumatic Diseases. 73. 766–767. 15 indexed citations
4.
Jamal, S. A., Östen Ljunggren, C. Stehman-Breen, et al.. (2010). The effects of denosumab on bone mineral density (BMD) and fracture by level of renal function. Bone. 47. S207–S208. 4 indexed citations
5.
Wattanakit, Keattiyoat, et al.. (2009). Chronic Kidney Disease Increases Risk for Venous Thromboembolism. Journal of Vascular Surgery. 49(1). 273–273. 9 indexed citations
6.
Gillen, Daniel L., C. Stehman-Breen, Jodi M. Smith, et al.. (2008). Survival Advantage of Pediatric Recipients of a First Kidney Transplant Among Children Awaiting Kidney Transplantation. American Journal of Transplantation. 8(12). 2600–2606. 70 indexed citations
7.
Geronemus, Robert, et al.. (2008). Anemia treatment with Q2W darbepoetin alfa in patients with chronic kidney disease naïve to erythropoiesis-stimulating agents. Current Medical Research and Opinion. 25(1). 123–131. 5 indexed citations
9.
Fried, Linda F., Michael G. Shlipak, C. Stehman-Breen, et al.. (2006). Kidney Function Predicts the Rate of Bone Loss in Older Individuals: The Cardiovascular Health Study. The Journals of Gerontology Series A. 61(7). 743–748. 38 indexed citations
10.
Katz, Lois, et al.. (1999). Principles of dialysis: special issues in women.. PubMed. 19(2). 140–7. 13 indexed citations
11.
Stehman-Breen, C., et al.. (1998). Risk of death among chronic dialysis patients infected with hepatitis C virus. American Journal of Kidney Diseases. 32(4). 629–634. 147 indexed citations
12.
Stehman-Breen, C., et al.. (1995). Hepatitis C virus associated membranous glomerulonephritis.. PubMed. 44(3). 141–7. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026